Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-18 Option Award | 2023-09-20 6:58 pm | 2023-10-18 2033-09-17 | COMPASS Pathways plc | CMPS | Karydas Daphne Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2023-09-13 Option Award | 2023-09-14 4:13 pm | N/A 2033-09-13 | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2022-11-16 Disposition | 2022-11-17 9:07 pm | N/A 2032-06-17 | LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director | 12,500 | $0 | 0 (Direct) | View |
| 2022-06-17 Option Award | 2022-07-05 06:59 am | N/A 2032-06-17 | LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-14 8:00 pm | N/A 2031-06-11 | LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:22 pm | N/A 2031-02-03 | Syndax Pharmaceuticals Inc | SNDX | Karydas Daphne Chief Financial Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-14 4:46 pm | N/A 2030-12-10 | LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-07-13 08:28 am | N/A 2030-05-12 | Syndax Pharmaceuticals Inc | SNDX | Karydas Daphne Chief Financial Officer | 0 | $0 | 215,000 (Direct) | View |